People · Operator
Named in public records as an officer, director or promoter · active 2009–2010 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Nfocus Neuromedical, Inc. | — | Other Health Care | Series A | $18.5M | $152.2M | 2009 |
| Fe3 Medical, Inc. | — | Biotechnology | Seed | $5.4M | $177.1M | 2010 |
| Neurolink, Inc. | — | Biotechnology | Seed | $3.9M | $100.4M | 2010 |
| Corhythm, Inc. | — | Biotechnology | Seed | $3.8M | $100.2M | 2010 |
Mir A Imran at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mir A Imran on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Syed A. Zaidi | 3 | 3 |
| Phil A. Morgan | 2 | 2 |
| Martin Dieck | 1 | 7 |
| Roger J. Quy | 1 | 4 |
| Omar A. Amirana | 1 | 2 |
| Eric Milledge | 1 | 2 |
| Omar Amirana, M.D. | 1 | 1 |
| Wayne A. Roe | 1 | 1 |
| Jill Papp | 1 | 1 |
| Ron A. Berenson | 1 | 1 |
| Eric J Milledge | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.